| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2025-12-28 | FY 2023
FILED 2024-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $3.20B | $3.15B | $3.24B |
| YoY Revenue Growth % | +1.6% | -2.8% | — |
| Gross Profit | $1.25B | $1.25B | — |
| Gross Margin % | 39.1% | 39.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $574.9M | $644.1M | $652.4M |
| Operating Margin % | 18.0% | 20.4% | 20.1% |
| Net Income (GAAP) | $367.3M | $428.4M | $400.9M |
| EBITDA (Normalized) | $631.5M | $673.5M | $769.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $630.2M | $686.8M | $628.8M |
| Capital Expenditures (CapEx) | $70.7M | $36.7M | $145.9M |
| Free Cash Flow (FCF) | $559.5M | $650.1M | $482.9M |
| FCF Margin % | 17.5% | 20.6% | 14.9% |
| Return on Invested Capital (ROIC %) | 9.7% | 9.5% | 21.9% |
| Cash & Short-Term Equivalents | $222.2M | $638.8M | — |
| Total Debt (Short + Long Term) | $2.13B | $2.35B | $910.4M |
| Total Stockholders' Equity | $2.78B | $3.64B | $1.87B |